Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Uterine Cervical Neoplasms 8Squamous Cell Carcinoma of Head and Neck 5Small Cell Lung Carcinoma 5Stomach Neoplasms 4Neuroblastoma 4Fallopian Tube Neoplasms 4Urinary Bladder Neoplasms 3Ovarian Neoplasms 3Medulloblastoma 3Ganglioneuroblastoma 3Gallbladder Neoplasms 3Cholangiocarcinoma 3Brain Neoplasms 3Urethral Neoplasms 2Ureteral Neoplasms 2Pancreatic Neoplasms 2Lung Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Hepatocellular 2Brenner Tumor 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Triple Negative Breast Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Solid Neoplasms 1Sarcoma 1Rhabdoid Tumor 1Recurrent Uterine Corpus Carcinoma 1

Interventions

berzosertib 1Platinum 1Gemcitabine 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Metastatic Bladder Urothelial Carcinoma × Platinum × Clear all
NCT02567409 2025-03-03

Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer

National Cancer Institute (NCI)

Phase 2 Completed
87 enrolled 13 charts
Genitourinary

Metastatic Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡